Cargando…

Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by dopaminergic neurodegeneration, motor impairment and non-motor symptoms. Epidemiological and experimental investigations into potential risk factors have firmly established that dietary factor caffeine, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiangpeng, Chen, Jiang-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773776/ https://www.ncbi.nlm.nih.gov/pubmed/33390888 http://dx.doi.org/10.3389/fnins.2020.602697

Ejemplares similares

Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
por: Luan, Yanan, et al.
Publicado: (2018)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Salivary caffeine in Parkinson’s disease
por: Leodori, Giorgio, et al.
Publicado: (2021)

The emerging role of circular RNAs in Parkinson’s disease
por: Liao, Jiajia, et al.
Publicado: (2023)

Caffeine Promotes Global Spatial Processing in Habitual and Non-Habitual Caffeine Consumers
por: Giles, Grace E., et al.
Publicado: (2013)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

Emerging Treatment Approaches for Parkinson’s Disease
por: Stoker, Thomas B., et al.
Publicado: (2018)

The Emerging Role of Neuropeptides in Parkinson’s Disease
por: Zheng, Yanan, et al.
Publicado: (2021)

Cautionary optimism: caffeine and Parkinson’s disease risk
por: Sokol, Leonard L., et al.
Publicado: (2016)

Potential Role of Caffeine in the Treatment of Parkinson’s Disease
por: Roshan, Mohsin H.K., et al.
Publicado: (2016)

Differentiation of Parkinson’s disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging
por: Ren, Qingguo, et al.
Publicado: (2022)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson’s Disease
por: Huang, Huan-jie, et al.
Publicado: (2018)

Post-Cueing Deficits with Maintained Cueing Benefits in Patients with Parkinson’s Disease Dementia
por: Gräber, Susanne, et al.
Publicado: (2014)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease
por: Zhang, Meng, et al.
Publicado: (2021)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Early detection of Parkinson’s disease from multiple signal speech: Based on Mandarin language dataset
por: Wang, Qiyue, et al.
Publicado: (2022)

Energy Drinks and the Neurophysiological Impact of Caffeine
por: Persad, Leeana Aarthi Bagwath
Publicado: (2011)

Caffeine Taste Signaling in Drosophila Larvae
por: Apostolopoulou, Anthi A., et al.
Publicado: (2016)

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
por: Vazey, Elena M., et al.
Publicado: (2012)

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
por: Wang, Ji, et al.
Publicado: (2020)

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease
por: Kistner, Andrea, et al.
Publicado: (2014)

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
por: Zhang, Yanyan, et al.
Publicado: (2021)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
por: Li, Song, et al.
Publicado: (2022)

The mechanism of exercise for pain management in Parkinson’s disease
por: Yu, Wen-Ye, et al.
Publicado: (2022)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
por: Zhang, Peng, et al.
Publicado: (2022)

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
por: Cabezudo, Diego, et al.
Publicado: (2020)

Deep Brain Stimulation Modulates Multiple Abnormal Resting-State Network Connectivity in Patients With Parkinson’s Disease
por: Bai, Yutong, et al.
Publicado: (2022)

Lead location as a determinant of motor benefit in subthalamic nucleus deep brain stimulation for Parkinson’s disease
por: Vitek, Jerrold L., et al.
Publicado: (2022)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Time course of tolerance to the performance benefits of caffeine
por: Lara, Beatriz, et al.
Publicado: (2019)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

Do caffeine and more selective adenosine A(2A) receptor antagonists protect against dopaminergic neurodegeneration in Parkinson’s disease?
por: Chen, Jiang-Fan, et al.
Publicado: (2020)

Recovery from Multiple APAs Delays Gait Initiation in Parkinson’s Disease
por: Cohen, Rajal G., et al.
Publicado: (2017)

Abnormal brain activities in multiple frequency bands in Parkinson’s disease with apathy
por: Xu, Haikun, et al.
Publicado: (2022)

Differentiation of Cerebellum-Type and Parkinson-Type of Multiple System Atrophy by Using Multimodal MRI Parameters
por: Cui, Bin, et al.
Publicado: (2021)

The Mechanism and Function of Glia in Parkinson's Disease
por: Zhang, Xinguo, et al.
Publicado: (2022)

Delirium, Caffeine, and Perioperative Cortical Dynamics
por: Kim, Hyoungkyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f3sp1uto8l3mk8pjssprvrh6cs